Physicochemical properties of recombinant hepatitis B surface antigen expressed in mammalian cell (C127)
The physicochemical properties of recombinant hepatitis B surface antigen (r-HBsAg), which was expressed in C127 mammalian cell were studied. Using roller bottle culture in DMEM supplemented with fetal bovine serum, 10–15 mg/L of r-HBsAg was produced with about 31% of purification yield. The purity of r-HBsAG by HPLC was 99.8% and electron microscopic examination showed homogeneous spherical particle with 22 nm in diameter, a morphological characteristic of HBsAg. The density of r-HBsAg by CsCl density gradient method was 1.19 g/ml and the isoelectric point by Mono PTM HR 5/20 column was 4.6. The analysis of subunit protein pattern using SDS-PAGE followed by scanning densitometry gave 81.3% of S protein and 18.7% of pre-S protein. Fluorophore-assisted-carbohydrate-electrophoresis analysis showed the relative amount of carbohydrate to protein was 1.7% and its major component was N-acetyl glucosamine, which was about 39% of total carbohydrate. The relative amount of lipid to protein determined by vanillin phosphoric acid method was 32.5% and its major component was phospholipid, which was about 70% of total lipid. The physicochemical properties of C127 mammalian cell-derived r-HBsAg are similar to those of p-HBsAg, suggesting that the r-HBsAg can be used in developing a new preventive vaccine against hepatitis B.
Key wordsRecombinant hepatitis B surface antigen Physicochemical properties Mouse fibroblast cell (C127) Fluorophore-assisted carbohydrate electrophoresis
- Akahane, Y., Clinical trial of a pre-S2 containing hepatitis B vaccine: Early response of anti pre-S2 in vaccines and efficacy in non-responders to conventional vaccines.International Symposium on Viral Hepatitis and Liver Disease. May 10–14, Tokyo, Japan (1993).Google Scholar
- Beasley, R. P. and Hwang, L. Y., Inviral hepatitis and liver disease. Grune & Stratton, New York. pp 209–224 (1984).Google Scholar
- Krone, B., Gerlich, W. H., Heermann, K. H., Lenz, A., Lu, X., Seiter, M. and Tomslen, R., Significance of pre-antigens for hepatitis B vaccines.Progress in hepatitis B immunization. 194, 21–25 (1990).Google Scholar
- Thoma, H. A., Hemmerling, A. E. and Hotzinger, H., Evaluation of immune response in a third generation hepatitis B vaccine containing pre-S proteins in comparative trials.Progress in hepatitis B immunization. 194, 35 (1990).Google Scholar